12/04/2025
At Vivid Clear Rx, we’re continually expanding access to high-value therapies that improve member health while reducing overall pharmacy spend. Our newest step forward: partnering with Mark Cuban Cost Plus Drug Company on Starjemza, a biosimilar alternative to Stelara, to support more affordable specialty care with full transparency and streamlined delivery.
It’s another way we’re driving smarter, more sustainable benefits for both members and employers.